Skip to main content
. 2021 Jul 6;11:13906. doi: 10.1038/s41598-021-93293-7

Table 2.

Distribution and extent of PAS across PACG disease severity (N = 267).

All eyes Mild PACG
N = 80
Moderate PACG
N = 71
Severe PACG
N = 116
p-value
Proportion of subjects with PAS, N (%)
122 (45.7) 31 (38.8) 27 (38.0) 64 (55.2) 0.02*
Superior PAS, N (%) 97 (79.5) 22 (71.0) 21 (77.8) 54 (84.4) 0.31
Nasal PAS, N (%) 53 (43.4) 13 (41.9) 9 (33.3) 31 (48.4) 0.41
Inferior, N (%) 55 (45.1) 17 (54.8) 9 (33.3) 29 (45.3) 0.26
Temporal, N (%) 46 (37.7) 10 (32.3) 11 (40.7) 25 (39.1) 0.76
Total Clock hours of PAS
3.84 ± 2.64 3.45 ± 2.16 3.15 ± 2.32 4.31 ± 2.91 0.10
Superior 1.64 ± 1.11 1.32 ± 1.11 1.44 ± 1.09 1.87 ± 1.08 0.046**
Nasal 0.85 ± 1.12 0.77 ± 1.02 0.57 ± 0.95 1.00 ± 1.21 0.23
Inferior 0.75 ± 1.00 0.87 ± 0.99 0.59 ± 0.97 0.77 ± 1.04 0.58
Temporal 0.60 ± 0.89 0.48 ± 0.77 0.54 ± 0.72 0.68 ± 1.00 0.56

PAS peripheral anterior synechiae, PACG primary angle closure glaucoma.

*Mild vs Severe PACG and Moderate vs Severe PACG = 0.02.

**Mild vs Severe PACG = 0.07.